Dow Up0.12% Nasdaq Up1.35%

Alexza Pharmaceuticals Inc. (ALXA)

-NasdaqGM
2.08 0.08(3.70%) Oct 20, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,484   2,166   1,309   2,166  
Cost of Revenue4,903  3,791  4,297  3,951  
Gross Profit (3,419) (1,625) (2,988) (1,785)
Operating Expenses
Research Development4,032  3,130  2,607  5,457  
Selling General and Administrative3,898  4,048  3,762  3,097  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,349) (8,803) (9,357) (10,339)
Income from Continuing Operations
Total Other Income/Expenses Net7,601  (1,144)4,108  (1,612)
Earnings Before Interest And Taxes(3,748)(9,947)(5,249)(11,951)
Interest Expense2,214  788  443  461  
Income Before Tax(5,962)(10,735)(5,692)(12,412)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,962)(10,735)(5,692)(12,412)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,962) (10,735) (5,692) (12,412)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,962) (10,735) (5,692) (12,412)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.